Project Grant R01CA303567
Award Date 8/14/26
Completion Date 7/31/31
Dollars Obligated $662K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43214, USA
Similar Awards
- The National Institutes of Health National Cancer Institute awarded Cincinnati Children's Hospital Medical Center $694,182 on June 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a prospective longitudinal cohort study examining biomarker levels and respiratory health effects associated with exposure to electronic cigarettes and combustible cigarettes in young children. The research enrolls 300 children ages 1 to 10 years across three equal exposure...
- The National Cancer Institute of the National Institutes of Health awarded the University of Southern California $426,828 on July 6, 2026, through the Cancer Cause and Prevention Research program (CFDA 93.393) to test regulatory strategies promoting e-cigarette cessation among young adults. The University of Southern California will conduct a study using a simulated vape shop experimental laboratory space ("The Puff Point") to evaluate two innovative policy interventions designed to...
- The National Cancer Institute awarded the University of Southern California $733,023 on September 3, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct randomized experiments and eye-tracking studies examining how influencer-driven e-cigarette marketing on social media affects adolescent perceptions and use patterns. The project will conduct two randomized between-subject experiments among 6,000 adolescents per experiment recruited nationwide and an...
- The National Institutes of Health National Cancer Institute awarded The Medical University of South Carolina $586,018 on July 10, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to conduct a three-arm clinical trial testing augmented doses of nicotine replacement therapy for individuals who use both combustible cigarettes and e-cigarettes and wish to quit both products. The trial will randomize dual-use participants to receive behavioral support combined with...
- The National Cancer Institute awarded the University of Rochester $583,304 on August 13, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to investigate toxicological assessment of emerging nicotine analogs in electronic nicotine delivery systems (ENDS). The research addresses a substantial knowledge gap regarding the safety profile of novel nicotine analogs, including 6-methyl nicotine and nicotinamide, which manufacturers have introduced to circumvent premarket...
- The National Institute of Environmental Health Sciences awarded $448,686 to the Research Institute At Nationwide Children's Hospital on September 1, 2026, under the Environmental Health program (CFDA 93.113) to investigate how electronic cigarette vapor affects formation of intracellular bacterial communities and recurrence of otitis media caused by nontypeable Haemophilus influenzae. The research examines the molecular mechanisms through which passive exposure to e-cigarette aerosol and...
- The National Institutes of Health Office of the Director awarded The Ohio State University $773,576 on August 1, 2026, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) to conduct research on oral nicotine pouches and their abuse liability. The research will investigate how freebase nicotine fraction and moisture content in oral nicotine pouches affect the speed of nicotine delivery to users and how acute laboratory measures of abuse...
- The National Cancer Institute awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center division, $948,630 under the Cancer Cause and Prevention Research program (CFDA 93.393) on August 1, 2026, for a naturalistic cohort study examining the real-world effectiveness of smoking cessation aids in US adults. The project will conduct a longitudinal survey study using the Understanding America Study, a nationally representative panel of 20,000 US...
- The National Cancer Institute awarded the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center division, $179,403 on August 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to examine longitudinal effects of nicotine pouch use on tobacco use behaviors, biomarkers, and nicotine dependence among U.S. adults. The research will harmonize nationally representative population assessment data from the PATH (Population...
- The National Cancer Institute awarded the Regents of the University of Michigan $158,895 under the Cancer Research Manpower program (CFDA 93.398) on May 1, 2026, for a project grant (K01CA308939) running through April 30, 2031. The funded research applies causal machine learning methods to enhance understanding of e-cigarette adoption and tobacco control interventions. The project focuses on analyzing survey data and comprehensive tobacco-related datasets to identify modifiable risk factors...